Long-term Consistency in Rotavirus Vaccine Protection: RV5 and RV1 Vaccine Effectiveness in US Children, 2012-2013.
AUTHORS
Payne
DC ,
Selvarangan
R ,
Azimi
PH ,
Boom
JA ,
Englund
JA ,
Staat
MA ,
Halasa
NB ,
Weinberg
GA ,
Szilagyi
PG ,
Chappell
J ,
McNeal
M ,
Klein
EJ ,
Sahni
LC ,
Johnston
SH ,
Harrison
CJ ,
Baker
CJ ,
Bernstein
DI ,
Moffatt
ME ,
Tate
JE ,
Mijatovic-Rustempasic
S ,
Esona
MD ,
Wikswo
ME ,
Curns
AT ,
Sulemana
I ,
Bowen
MD ,
Gentsch
JR ,
Parashar
UD ,
. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2015 10 8; ().
- PMID: 26449565 [PubMed].
ABSTRACT
Using a multi-center, active surveillance network from two rotavirus seasons (2012 and 2013), we assessed the vaccine effectiveness of RV5 (RotaTeq) and RV1 (Rotarix) rotavirus vaccines in preventing rotavirus gastroenteritis hospitalizations and emergency department (ED) visits for numerous demographic and secular strata.
Using a multi-center, active surveillance network from two rotavirus seasons (2012 and 2013), we assessed the vaccine effectiveness of RV5 (RotaTeq) and RV1 (Rotarix) rotavirus vaccines in preventing rotavirus gastroenteritis hospitalizations and emergency department (ED) visits for numerous demographic and secular strata.
Tags: Alumni Publications 2015